CollPlant Biotechnologies Ltd (CLGN) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
CLGN currently has 14.4M outstanding shares. with significant dilution risk as 11.1M authorized shares could dilute existing holders by 76.8%. The company has significantly diluted shareholders by 29.14% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Mar 30, 2026 |
F-1 filing: This is an F-1 filing for an offering of ordinary shares issuable upon exercise of warrants by selling shareholders. |
14M | 11M |
| Mar 26, 2026 |
20-F filing | 12.2M shares outstanding |
12M | 10M |
| Jun 17, 2025 |
F-1 filing: This F-1 filing describes an offering of ordinary shares issuable upon exercise of Investor Warrants and Placement Agent Warrants. |
13M | 9.5M |
| Mar 26, 2025 |
20-F filing | 11.5M shares outstanding |
11M | 9.5M |
| Apr 04, 2024 |
20-F filing | 11.4M shares outstanding |
11M | 9.5M |
| Mar 29, 2023 |
20-F filing | 11.0M shares outstanding |
11M | 9.9M |
| Dec 30, 2022 |
F-3 filing: CollPlant Biotechnologies Ltd. may offer, issue and sell from time to time up to US $100,000,000 of our ordinary shares, including in the form of warrants to purchase ordinary shares, subscription rights, and a combination of such securities, separately or as units, in one or more offerings. |
10M | 11M |
| Mar 24, 2022 |
20-F filing | 10.0M shares outstanding |
10M | 0 |
| Mar 26, 2021 |
20-F filing | 7.0M shares outstanding |
7M | 2M |
| May 27, 2020 |
F-3 filing: This F-3 filing relates to the resale of up to 3,271,786 ordinary shares represented by ADSs by selling shareholders. |
5.7M | 3.3M |
| Apr 01, 2020 |
20-F filing | 5.7M shares outstanding |
5.7M | 0 |